Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Bradyarrhythmia

3,4-dihydroxyphenylacetic acid has been researched along with Bradyarrhythmia in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delgado, M1
Caicoya, AG1
Greciano, V1
Benhamú, B1
López-Rodríguez, ML1
Fernández-Alfonso, MS1
Pozo, MA1
Manzanares, J1
Fuentes, JA1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Bradyarrhythmia

ArticleYear
Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    European journal of pharmacology, 2005, Mar-21, Volume: 511, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adenylyl Cyclase Inhibitors;

2005